A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)
Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.
Hospital for Tropical Diseases, Ho CHi Minh City, Vietnam
Children's Hospital 1, Ho Chi Minh City, Vietnam
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of
Jawaharlal Nehru Medical College, Karnataka Lingayat Education University, Belgaum, Karnataka, India
Aga Khan University, Karachi, Sindh, Pakistan
Centro de Investigacaoem Saude de Manhica (CISM), Maputo, Mozambique
Center of Respiratory Disorders,Children's Hospital,Chongqing Medical University, Chongqing, Chongqing, China
Kasr Alainy hospital, Cairo, Egypt
Alzahra, Isfahan, Iran, Islamic Republic of
Hospital Federal de Bonsucesso, Rio de Janeiro, RJ, Brazil
Instituto Nacional de Câncer, Rio de Janeiro, Brazil
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.